Although our data indicate that GIPR is not a receptor for TFF1, TFF1 and GIPR seem to be involved in the same signaling cascades, and up- and downstream signaling mediators like miR-542-5p and p53 are potential targets for new retinoblastoma treatment approaches. This evidence concerns the gene GIPR and retinoblastoma.